193 related articles for article (PubMed ID: 22171564)
1. Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.
Relan A; Bakhtiari K; van Amersfoort ES; Meijers JC; Hack CE
BioDrugs; 2012 Feb; 26(1):43-52. PubMed ID: 22171564
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.
Hack CE; Mannesse M; Baboeram A; Oortwijn B; Relan A
BioDrugs; 2012 Oct; 26(5):303-13. PubMed ID: 22928662
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
[TBL] [Abstract][Full Text] [Related]
6. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.
Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE
Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891
[TBL] [Abstract][Full Text] [Related]
7. Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of ige antibodies.
Hack CE; Relan A; Baboeram A; Oortwijn B; Versteeg S; van Ree R; Pijpstra R
Clin Drug Investig; 2013 Apr; 33(4):275-81. PubMed ID: 23463274
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
[TBL] [Abstract][Full Text] [Related]
9. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.
Varga L; Farkas H
Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study.
Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A
Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116
[TBL] [Abstract][Full Text] [Related]
12. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
Bernstein JA; Relan A; Harper JR; Riedl M
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978
[TBL] [Abstract][Full Text] [Related]
13. Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk.
van den Elzen MT; van Os-Medendorp H; Röckmann-Helmbach H; van Hoffen E; Lebens AF; van Doorn H; Klemans RJ; Bruijnzeel-Koomen CA; Hack CE; Kaufman L; Relan A; Knulst AC
J Allergy Clin Immunol; 2016 Aug; 138(2):476-481.e1. PubMed ID: 27321437
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein levels in hereditary angioedema.
Hofman ZL; Relan A; Hack CE
Clin Exp Immunol; 2014 Jul; 177(1):280-6. PubMed ID: 24588117
[TBL] [Abstract][Full Text] [Related]
15. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J
J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064
[TBL] [Abstract][Full Text] [Related]
17. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
19. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.
van Geffen M; Cugno M; Lap P; Loof A; Cicardi M; van Heerde W
Clin Exp Immunol; 2012 Mar; 167(3):472-8. PubMed ID: 22288590
[TBL] [Abstract][Full Text] [Related]
20. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
Mol Immunol; 2020 Mar; 119():27-34. PubMed ID: 31955064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
